Alps Advisors Inc Opko Health, Inc. Transaction History

Alps Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.87 - $1.57 $39,037 - $70,447	-44,871 Reduced 8.36%	491,610 $589,000
Q4 2023 Feb 14, 2024	BUY	$1.23 - $1.63 $659,871 - $874,464	536,481 New	536,481 $810,000
Q1 2023 May 10, 2023	SELL	$1.06 - $1.61 $16,469 - $25,014	-15,537 Reduced 2.96%	509,055 $743,000
Q4 2022 Feb 14, 2023	BUY	$1.05 - $2.01 $108,347 - $207,407	103,188 Added 24.49%	524,592 $655,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.81 $30,520 - $47,382	16,862 Added 4.17%	421,404 $796,000
Q2 2022 Aug 11, 2022	SELL	$2.33 - $3.61 $689,274 - $1.07 Million	-295,826 Reduced 42.24%	404,542 $1.02 Million
Q1 2022 May 16, 2022	SELL	$2.87 - $4.93 $253,024 - $434,638	-88,162 Reduced 11.18%	700,368 $2.41 Million
Q4 2021 Feb 09, 2022	BUY	$3.52 - $5.15 $2.78 Million - $4.06 Million	788,530 New	788,530 $3.79 Million
Q4 2017 Feb 05, 2018	SELL	$4.61 - $7.04 $2.54 Million - $3.88 Million	-550,909 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$5.88 - $7.11 $3.24 Million - $3.92 Million	550,909	550,909 $3.78 Million

256

186M

6.03M

10.1M

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.17B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.